Literature DB >> 26752936

Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.

Sylvain Favelier1, Louis Estivalet1, Pierre Pottecher1, Romaric Loffroy1.   

Abstract

Entities:  

Year:  2015        PMID： 26752936      PMCID： PMC4697100          DOI： 10.3978/j.issn.1000-9604.2015.07.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  62 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 2.  Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy.

Authors:  Vahid Yaghmai; Cecilia Besa; Edward Kim; Joseph L Gatlin; Nasir A Siddiqui; Bachir Taouli
Journal:  AJR Am J Roentgenol       Date:  2013-07       Impact factor: 3.959

Review 3.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

4.  Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.

Authors:  Zhijun Wang; Mingde Lin; David Lesage; Rongxin Chen; Julius Chapiro; Tara Gu; Vania Tacher; Rafael Duran; Jean-François Geschwind
Journal:  Acad Radiol       Date:  2014-03       Impact factor: 3.173

5.  Hepatic tumors: region-of-interest versus volumetric analysis for quantification of attenuation at CT.

Authors:  Hamid Chalian; Sandra M Tochetto; Hüseyin G Töre; Pedram Rezai; Vahid Yaghmai
Journal:  Radiology       Date:  2012-03       Impact factor: 11.105

6.  Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?

Authors:  Satoshi Goshima; Masayuki Kanematsu; Hiroshi Kondo; Ryujiro Yokoyama; Yusuke Tsuge; Yoshimune Shiratori; Minoru Onozuka; Noriyuki Moriyama
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

Review 7.  Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.

Authors:  Anwar R Padhani
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

8.  Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.

Authors:  Zheng Yuan; Xiao-Dan Ye; Sheng Dong; Li-Chao Xu; Xue-Yuan Xu; Shi-Yuan Liu; Xiang-Sheng Xiao
Journal:  Eur J Radiol       Date:  2009-06-18       Impact factor: 3.528

9.  Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.

Authors:  Jin Iwazawa; Shoichi Ohue; Naoko Hashimoto; Osamu Muramoto; Takashi Mitani
Journal:  Eur J Radiol       Date:  2012-09-05       Impact factor: 3.528

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.